a leading provider and developer of advanced personal telemedicine solutions is
pleased to announce that it has been informed by Prime Finance Corporation (a
company affiliated with Mr. Eyal Ofer) and Copper Valley Finance Ltd (a company
affiliated with Prof. Shlomo Ben Haim) that they have purchased 1,431,607 shares of
SHL’s issued share capital (excluding treasury shares held by SHL) and Copper Valley
Finance Ltd has purchased 715,803 shares, which account for 6.90% of SHL’s issued
share capital (excluding treasury shares held by SHL).
2012, a subsidiary of SHL has signed a Joint Venture Agreement with companies which
are affiliated with Mr. Eyal Ofer and Prof. Shlomo Ben Haim, in order to found a joint
venture entity, which will explore the feasibility of SHL’s activity in the Japanese market.
About SHL Telemedicine
SHL Telemedicine Ltd. specializes in developing and marketing advanced personal
telemedicine systems as well as providing comprehensive telemedicine solutions
including medical call centers to individuals and to the healthcare community. As a
leading provider of remote health services in cardiology and in other medical areas, SHL
maintains business operations in Europe, mainly in Germany, and at its home market in
Israel. In the US, certain SHL telemedicine products are distributed by Philips
Healthcare. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885,
Security No.: 1128957). More information available at: www.shl-telemedicine.com.
For further information please contact:
- Erez Alroy, Co-CEO, Phone: +972 3561 22 12, email@example.com
- Martin Meier-Pfister, IRF Communications, Phone: +41 43 244 81 40, firstname.lastname@example.org
Readers are cautioned that any such forward-looking statements are not guarantees of future
performance and involve risks and uncertainties, and that actual results may differ materially from
those in the forward-looking statements as a result of various factors. SHL Telemedicine
undertakes no obligation to publicly update or revise any forward-looking statements.